Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC ZYDUS LIFESCIENCES ALEMBIC/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 25.3 20.0 126.3% View Chart
P/BV x 0.7 2.4 31.4% View Chart
Dividend Yield % 2.5 0.6 395.5%  

Financials

 ALEMBIC   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ALEMBIC
Mar-22
ZYDUS LIFESCIENCES
Mar-22
ALEMBIC/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs143674 21.3%   
Low Rs72331 21.8%   
Sales per share (Unadj.) Rs3.0149.1 2.0%  
Earnings per share (Unadj.) Rs3.422.7 14.8%  
Cash flow per share (Unadj.) Rs3.529.7 11.9%  
Dividends per share (Unadj.) Rs1.802.50 72.0%  
Avg Dividend yield %1.70.5 336.0%  
Book value per share (Unadj.) Rs97.2166.1 58.6%  
Shares outstanding (eoy) m256.781,023.74 25.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x35.33.4 1,049.0%   
Avg P/E ratio x32.122.1 145.1%  
P/CF ratio (eoy) x30.416.9 179.4%  
Price / Book Value ratio x1.13.0 36.6%  
Dividend payout %53.611.0 487.4%   
Avg Mkt Cap Rs m27,643514,277 5.4%   
No. of employees `000NANA-   
Total wages/salary Rs m21521,777 1.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m782152,652 0.5%  
Other income Rs m8922,354 37.9%   
Total revenues Rs m1,674155,006 1.1%   
Gross profit Rs m13934,427 0.4%  
Depreciation Rs m497,130 0.7%   
Interest Rs m41,270 0.3%   
Profit before tax Rs m97928,381 3.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1175,117 2.3%   
Profit after tax Rs m86223,264 3.7%  
Gross profit margin %17.822.6 79.0%  
Effective tax rate %11.918.0 66.1%   
Net profit margin %110.215.2 723.1%  
BALANCE SHEET DATA
Current assets Rs m1,433122,614 1.2%   
Current liabilities Rs m67878,394 0.9%   
Net working cap to sales %96.629.0 333.5%  
Current ratio x2.11.6 135.2%  
Inventory Days Days10,34693 11,160.4%  
Debtors Days Days71080 889.3%  
Net fixed assets Rs m24,886144,382 17.2%   
Share capital Rs m5141,024 50.2%   
"Free" reserves Rs m24,452168,972 14.5%   
Net worth Rs m24,966169,996 14.7%   
Long term debt Rs m03,621 0.0%   
Total assets Rs m26,320266,996 9.9%  
Interest coverage x252.623.3 1,081.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.6 5.2%   
Return on assets %3.39.2 35.8%  
Return on equity %3.513.7 25.2%  
Return on capital %3.917.1 23.0%  
Exports to sales %2.00-   
Imports to sales %0.314.3 2.0%   
Exports (fob) Rs m16NA-   
Imports (cif) Rs m221,869 0.0%   
Fx inflow Rs m1663,065 0.0%   
Fx outflow Rs m221,869 0.0%   
Net fx Rs m1341,196 0.0%   
CASH FLOW
From Operations Rs m-17721,041 -0.8%  
From Investments Rs m18811,544 1.6%  
From Financial Activity Rs m-58-8,683 0.7%  
Net Cashflow Rs m-4723,729 -0.2%  

Share Holding

Indian Promoters % 70.9 75.0 94.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.0 15.5 31.9%  
FIIs % 0.8 2.6 31.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 25.0 116.4%  
Shareholders   83,612 408,231 20.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on ALEMBIC vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC vs Cadila Healthcare Share Price Performance

Period ALEMBIC Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.27% -0.67% 0.23%
1-Month 2.40% -7.08% 0.36%
1-Year -27.39% -12.51% -6.87%
3-Year CAGR 11.12% 15.53% 20.16%
5-Year CAGR 12.07% -1.99% 11.07%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ALEMBIC hold a 70.9% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 53.6%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of ALEMBIC, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 211 Points | Tyre Stocks Rally while Metals Drag | 4 Reasons Why Indian Share Markets Hit Record High(Closing)

After opening the day lower mirroring weakness in Asian peers, Indian share markets staged a comeback and ended the trading session on an optimistic note.